KEY FEATURES
| Full Name | Major Histocompatibility Complex Class Ⅰ G |
|---|---|
| Synonym | HLA-G5;MHC-G; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.63-40ng/mL |
| Sensitivity | 0.38ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human MHCG/HLA-G in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human MHCG/HLA-G. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human MHCG/HLA-G and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human MHCG/HLA-G, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human MHCG/HLA-G. You can calculate the concentration of Human MHCG/HLA-G in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human MHCG/HLA-G ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 2.01 | 3.81 | 18.73 | 2.17 | 3.7 | 18.22 |
| Standard deviation | 0.11 | 0.17 | 0.83 | 0.14 | 0.16 | 0.59 |
| CV(%) | 5.53 | 4.36 | 4.42 | 6.58 | 4.24 | 3.26 |
RECOVERY
The recovery of Human MHCG/HLA-G spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 94-111 | 101 |
| EDTA plasma (n=8) | 88-104 | 95 |
| Cell culture media (n=8) | 85-96 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human MHCG/HLA-G in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with MHCG ELISA Kits
| IL10 ELISA Kit | publications with MHCG and IL10 |
| KLRD1 ELISA Kit | publications with MHCG and KLRD1 |
| B2M ELISA Kit | publications with MHCG and B2M |
| ADM2 ELISA Kit | publications with MHCG and ADM2 |
| MMP15 ELISA Kit | publications with MHCG and MMP15 |
Pathways associated with MHCG ELISA Kit
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Allograft Rejection Pathway | Allograft Rejection Pathway |
| Antigen Presentation: Folding, Assembly And Peptide Loading Of Class I MHC Pathway | Antigen Presentation: Folding, Assembly And Peptide Loading Of Class I MHC Pathway |
| Antigen Processing And Presentation Pathway | Antigen Processing And Presentation Pathway |
| Antigen Processing-Cross Presentation Pathway | Antigen Processing-Cross Presentation Pathway |
| Autoimmune Thyroid Disease Pathway | Autoimmune Thyroid Disease Pathway |
Diseases associated with MHCG ELISA Kit
| Inflammation | publications with MHCG and Inflammation |
| Necrosis | publications with MHCG and Necrosis |
| Nervous System Diseases | publications with MHCG and Nervous System Diseases |
| Breast Neoplasms | publications with MHCG and Breast Neoplasms |
| Asthma | publications with MHCG and Asthma |
| Carcinoma, Squamous Cell | publications with MHCG and Carcinoma, Squamous Cell |
| Ovarian Neoplasms | publications with MHCG and Ovarian Neoplasms |
| Kidney Diseases | publications with MHCG and Kidney Diseases |
| Brain Diseases | publications with MHCG and Brain Diseases |
| Bone Marrow Diseases | publications with MHCG and Bone Marrow Diseases |
Organs/Tissues associated with MHCG ELISA Kit
| Placenta | publications with MHCG and Placenta |
| Lung | publications with MHCG and Lung |
| Brain | publications with MHCG and Brain |
| Thymus | publications with MHCG and Thymus |
| Stomach | publications with MHCG and Stomach |
| Intestine | publications with MHCG and Intestine |
| Pancreas | publications with MHCG and Pancreas |
| Testis | publications with MHCG and Testis |